Balanced Prosecution of Transnational Organized Crime Cases
Bureau of International Narcotics-Law Enforcement
Description
The Bureau of International Narcotics and Law Enforcement Affairs (INL) of the U.S. Department of State announce an open competition for organizations to submit applications to carry out a project to develop a software-based weighted, random case-allocation system to prevent selective prosecution of transnational organized crime and money laundering cases. Political interference in the prosecution service remains a barrier to fighting transnational organized crime and achieving other U.S. objectives in Serbia. As requested by the High Prosecutorial Council, the body responsible for oversight of the prosecution service, this grant will reduce political manipulation of prosecutions and improve outcomes in extradition cases and cases involving high-level corruption and transnational criminal organization (TCO) leaders whose activities harm U.S. national security interests through random allocation of cases
Award amount
$750,000 – $1,100,000
Total program funding: $1,100,000
Eligibility
Please see Section C. Eligibility Criteria under the Full Announcement. In addition, applicants must also meet specific requirements to be eligible to apply to this NOFO, please see Section C. Eligibility Criteria for all details.
This is a notice of funding opportunity (NOFO) for the BJA FY 2026 DNA Capacity Enhancement for Backlog Reduction (CEBR) - Formula Grants Program. This opportunity will support states and units of local government with existing crime laboratories that conduct DNA analysis to process, and/or to increase the capacity to process, more DNA samples for entry into the Combined DNA Index System (CODIS), thereby helping to reduce the number of forensic DNA and DNA database samples awaiting analysis and/or to prevent a backlog of forensic and database DNA samples.
This Notice of Funding Opportunity (NOFO) supports research to develop, implement, monitor, and evaluate technology-driven and cost-effective tools that reduce the global human rabies burden. It also measures progress toward canine rabies elimination, with an emphasis on high-burden countries. Priority research areas include:
Electronic systems for tracking human and dog rabies vaccinations. Managing human rabies exposure investigations. Enhancing rabies laboratory information management systems. Modeling the economic impact of dog-mediated rabies interventions. Estimating rabies-susceptible dog populations. The research is intended to generate data-driven strategies that help accelerate progress toward global canine rabies elimination and protect public health.
The proposed international hybrid Notice of Funding Opportunity (NOFO) will link non-research implementation with targeted research that advances CDC's mission to address antimicrobial resistance (AR) across multiple bacterial and fungal pathogens, healthcare-associated infections (HAIs), and emerging infectious disease threats including viral pathogens across healthcare, community, and environmental settings in low and middle-income countries. AR and HAI remain urgent global threats, with substantial mortality and economic impact. Building on CDC's Global AR Laboratory and Response Network, HAI surveillance and prevention networks, and other collaborating programs, the NOFO seeks to strengthen detection, surveillance, prevention, and response systems to reduce illness and death, stop the spread of AR, protect healthcare workers and patients, and lower costs through robust infection prevention and control (IPC) and antimicrobial stewardship.
This initiative will provide salary and research support to Low- and Middle-Income Country (LMIC) junior faculty and research scientists who are based at LMIC academic or research institutions for intensive mentored research and career development activities focused on biomedical, behavioral, and/or clinical research in LMICs. Proposals will leverage special opportunities not present in the U.S. and result in generalizable knowledge applicable to the health of U.S. and LMIC populations. Recipients are required to receive mentoring from senior U.S. and LMIC researchers, and projects must leverage existing NIH research investments. A sustained period of research career development will enable recipients to become global research leaders at their LMIC institutions, serve as mentors to the next generation of investigators, and strengthen international networks that support NIH research investments.